Certainty assessment | No. of patients | Effect | Certainty | Importance | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | Exercise | No. of exercise | Relative (95% CI) | Absolute (95% CI) | ||
Anti Mullerian hormone (follow-up: mean 12.33 weeks) | ||||||||||||
6 | Randomized trials | Very seriousa | Very seriousb | Not serious | Seriousc | None | 139 | 134 | - | SMD 0.66 SD more (0.06 more to 1.26 more) | ⨁◯◯◯ Very low | Critical |